Overview

Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study in to evaluate efficacy and tolerability of Clopirin and clopidogrel with aspirin in Korean Patients with post-percutaneous coronary artery intervention.
Phase:
Phase 4
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.
Treatments:
Aspirin
Clopidogrel
Ticlopidine